These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. [Influence of the change in the dose of Clofibrate Spofa and interruption of treatment on the lipid level of blood serum in persons with hyperlipemia]. Cagánová A; Cagán S Bratisl Lek Listy; 1972 Jul; 58(1):66-78. PubMed ID: 5077942 [No Abstract] [Full Text] [Related]
46. [CHOLESTEROL AND BLOOD LIPID BEHAVIOR IN ARTERIOSCLEROSIS UNDER THE EFFECTS OF PROTECTED ANDROSTERONE (ATROMID)]. MARIN R; GARCIAFERNANDEZ JL; GARCIAOTERO V; RODRIGUEZPUCHOL J; PESCADOR L Rev Esp Cardiol; 1964 Jul; 17():563-73. PubMed ID: 14232044 [No Abstract] [Full Text] [Related]
47. Factorial study of the efficacy of cholestyramine, L-tryptophan and clofibrate in human nephrotic hyperlipidaemia. Schapel GJ; Edwards KD; Neale FC Prog Biochem Pharmacol; 1974; 9():82-98. PubMed ID: 4438384 [No Abstract] [Full Text] [Related]
48. Efficacy and interactions of oxandrolone, halo-fenate and clofibrate in a factorial study on experimental acute nephrotic hyperlipidemia. Schapel GJ; Edwards KD J Pharmacol Exp Ther; 1975 Jul; 194(1):274-84. PubMed ID: 1171221 [TBL] [Abstract][Full Text] [Related]
51. [Bis-(hydroxy-2-ethylthyo)-1,10-decano in hyperlipaemic therapy (author's transl)]. Cucinotta D; Palummeri E; Ceccato S; Passeri M G Ital Cardiol; 1977; 7(3):248-64. PubMed ID: 858465 [TBL] [Abstract][Full Text] [Related]
52. [Clinical and therapeutic evaluation of a new antilipemic substance]. de Aguiar Magano L Arch Sci Med (Torino); 1980; 137(1):131-9. PubMed ID: 7458646 [TBL] [Abstract][Full Text] [Related]
53. A CONTROLLED TRIAL OF ATROMID IN CEREBRAL VASCULAR DISEASE. A PRELIMINARY REPORT. ACHESON J; HUTCHINSON EC J Atheroscler Res; 1963; 3():711-5. PubMed ID: 14100916 [No Abstract] [Full Text] [Related]
54. EFFECTS OF TRIPARANOL ON THE HYPERLIPEMIA OF EXPERIMENTAL NEPHROSIS. WAKIM KG; MCGUCKIN WF; BROWN AL; BAGGENSTOSS AH Proc Soc Exp Biol Med; 1965 Mar; 118():706-10. PubMed ID: 14264535 [No Abstract] [Full Text] [Related]
55. A STUDY OF THE EFFECT OF ATROMID THERAPY IN EXUDATIVE DIABETIC RETINOPATHY. IRELAND JT; CULLEN JF; OLIVER MF; DUNCAN LJ J Atheroscler Res; 1963; 3():701-8. PubMed ID: 14100915 [No Abstract] [Full Text] [Related]
56. [Action mechanism and clinical success of Regelan (Clofibrate)]. Fitzgerald JD Wien Klin Wochenschr; 1967 Sep; 79(39):716-20. PubMed ID: 5595437 [No Abstract] [Full Text] [Related]
57. [Treatment of essential hyperlipemia with clofibrate]. Reuter W; Seifert A Z Gesamte Inn Med; 1969 Jun; 24(12):184-7. PubMed ID: 5404292 [No Abstract] [Full Text] [Related]
58. [Essential familial xanthomatous hypercholesteremia and a therapy trial with triparanol]. MEISINGER FX Arztl Forsch; 1963 Jan; 17():39-44. PubMed ID: 13934599 [No Abstract] [Full Text] [Related]
59. Do fats matter. Jepson EM Trans Med Soc Lond; 1972; 88():12-21. PubMed ID: 4665812 [No Abstract] [Full Text] [Related]